Human pluripotent stem cells (hPSCs) represent a scalable source of cells for off-the-shelf therapeutics and advanced in vitro tissue models. However, their translational utility is constrained by inefficient differentiation protocols that rely on small molecules, cytokines, or genomic modification. Here, we describe a non-integrating approach that utilizes ionizable lipid nanoparticles (iLNPs) to deliver mRNA encoding the ETV2 transcription factor to efficiently forward reprogram hPSCs to endothelial cells (ECs). This platform achieved transfection efficiencies exceeding 97%, with robust expression of functional mRNA cargo. ETV2 delivery induced rapid endothelial conversion, generating cell populations with average purities greater than 90% based on expression of canonical endothelial surface markers Pecam-1 (CD31) and VE-Cadherin (CD144). Forward programming efficiency depended upon culture parameters including initial seeding density, mRNA dosage, and time after transfection. Functionally, iLNP-ETV2-derived ECs exhibited hallmark endothelial behaviors, including angiogenic network formation in vitro, uptake of acetylated low-density lipoprotein, and inflammatory cytokine responsiveness. Collectively, these findings establish iLNP-mediated ETV2 mRNA delivery as an efficient and non-genome-integrating strategy for forward programming hPSCs to ECs, facilitating their use in tissue engineering, disease modeling, and cell-based therapy applications. STATEMENT OF SIGNIFICANCE: Human pluripotent stem cells are a promising source of cells for regenerative medicine and tissue engineering, but existing differentiation methods often produce low yields and require extensive optimization. In this study, we demonstrate that ionizable lipid nanoparticles can achieve highly efficient mRNA delivery to pluripotent stem cells and enable efficient, non-integrating forward programming to endothelial cells through transient expression of the transcription factor ETV2. This approach generated highly pure endothelial populations that retained key endothelial functions and remained stable during long-term expansion. Importantly, endothelial conversion was maintained across broad ranges of cell seeding densities and mRNA doses, suggesting a robust and scalable manufacturing process. These findings establish a versatile platform for mRNA based cell engineering and stem cell differentiation.